H von Holst, P Nayak, Z Dembek, S Buehler… - Heliyon, 2021 - cell.com
Background Increased exposure to perfluoroalkyl substances (PFAS) potentially affects infant and childhood health through immunosuppression. Given rapidly evolving research …
L Zhang, A Louie, G Rigutto, H Guo, Y Zhao, S Ahn… - Environmental …, 2023 - Elsevier
Background The ability to induce chronic inflammation and immunosuppression are two key characteristics of carcinogens and important forms of immunotoxicity. The National …
K Mokra - International journal of molecular sciences, 2021 - mdpi.com
Endocrine disruptors are a group of chemical compounds that, even in low concentrations, cause a hormonal imbalance in the body, contributing to the development of various harmful …
LM Zell-Baran, C Venter, D Dabelea, JM Norris… - Environmental …, 2023 - Elsevier
Exposure to poly and perfluoroalkyl substances (PFAS) in early life may increase the risk of childhood asthma, but evidence has been inconsistent. We estimated associations between …
Perfluorooctane sulfonic acid (PFOS) is a long chain per-and polyfluoroalklyl substance (PFAS) that has been used in aqueous film-forming foams. Emerging epidemiological …
Background and objective Associations between exposure to per-and polyfluoroalkyl substances (PFAS) and pediatric asthma and reduced lung function in children are mixed …
Background Asthma is the most common non-communicable disease in children. Prenatal exposure to perfluoroalkyl substances (PFASs), a group of persistent environmental …
Concentrations of plasma per and poly-fluoroalkyl substances (PFAS) are elevated in the Inuit population of Nunavik and may be causing adverse health effects. Respiratory health …
H Goudarzi, K Yamazaki - Health Impacts of Developmental Exposure to …, 2020 - Springer
Perfluoroalkyl substances (PFASs) are highly stable and ubiquitous compounds which have been used for more than 60 years in various products; however, their potential health effects …